Screener
CVS Health CVS Assets, Fair Value Disclosure
Assets, Fair Value Disclosure at other companies
Other financials
Where this comes from
Reported directly by CVS Health in its filing.
Tagged under the XBRL concept us-gaap:AssetsFairValueDisclosure.
The source filing: CVS Health’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:33 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000064803-26-000098
| In millions / June 30, 2026 | Level 1 | Level 2 | Level 3 | Total |
|---|---|---|---|---|
| Redeemable preferred securities | — | 14 | — | 14 |
| Total debt securities | 2,564 | 26,782 | 3 | 29,349 |
| Equity securities | 8 | 217 | 199 | 424 |
| Total | $6,318 | $34,582 | $202 | $41,102 |
| December 31, 2025 | ||||
| Cash and cash equivalents | $4,030 | $4,423 | — | $8,453 |
| Debt securities: | ||||
| U.S. government securities | 2,713 | 9 | — | 2,722 |
Item 1.Financial Statements
FAQ
- What is CVS Health's assets, fair value disclosure?
- CVS Health (CVS) reported assets, fair value disclosure of $41.1B in Q2 2026.
- What does assets, fair value disclosure mean?
- Assets, Fair Value Disclosure as reported by CVS HEALTH CORPORATION.
Ask your AI about CVS Health's assets, fair value disclosure.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude